The following are medications commonly prescribed cardiac pharmaceutical agents. The specificity of the following medications is highly variable, and often are not particularly specific to a given class. As such, they are listed as are commonly accepted.
- Antiarrhythmic agents - group of pharmaceuticals that are used to suppress abnormally fast rhythms (tachycardias), such as atrial fibrillation, supraventricular tachycardia and ventricular tachycardia.
- Type I (sodium channel blockers)
- Type Ia
- Type Ib
- Type Ic
- Type II (beta blockers)
- Type III (potassium channel blockers)
- Type IV (slow calcium channel blockers)
- Type V
- Type I (sodium channel blockers)
- ACE inhibitors[1] - class of antihypertensives that work by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart.
- Alpha blockers:
- Angiotensin II receptor antagonists - class of antihypertensives that bind to and inhibit the angiotensin II receptor type 1 and thereby block the arteriolar contraction and sodium retention effects of renin–angiotensin system.
- Beta blocker
- Mixed Alpha + Beta blockers:
- bucindolol
- carvedilol
- labetalol
- clonidine (indirectly)
- Calcium channel blockers
- Antimineralocorticoid
- Antiplatelet drug
- Anticoagulant
- Fibrinolytics
- Diuretics
References
- ^ Herman, Linda L.; Padala, Sandeep A.; Ahmed, Intisar; Bashir, Khalid (2023), "Angiotensin-Converting Enzyme Inhibitors (ACEI)", StatPearls, Treasure Island (FL): StatPearls Publishing, PMID 28613705, retrieved 2023-10-04
This page was last edited on 26 October 2023, at 06:41